Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk FDA today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. Mon, 09 Nov 2026 17:15:46 EST FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherap Thu, 05 Nov 2026 17:30:38 EST FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality The U.S. Food and Drug Administration today issued final guidance for manufacturers of cellular and gene therapy (CGT) products to implement a comprehensive, science- and risk-based plan for making sure their products meet potency standards. Mon, 02 Nov 2026 08:56:06 EST FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis The U.S. Food and Drug Administration today granted accelerated approval for Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for treatment of adults with recurrent respiratory papillomatosis (RRP). Fri, 30 Oct 2026 16:32:08 EDT FDA Launches New Program to Advance Neuroscience Medical Product Development FDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments. Thu, 22 Oct 2026 12:58:19 EDT FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis. Tue, 20 Oct 2026 15:40:38 EDT FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. Tue, 20 Oct 2026 11:57:36 EDT FDA Issues Final Guidance on Prescription Drug Apps and Software The U.S. Food and Drug Administration today released final guidance establishing a clear framework for how drug companies can develop, distribute, and label apps used alongside their prescription medicines. Tue, 20 Oct 2026 09:03:14 EDT FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that may allow some patients with locally advanced rectal cancer to avoid common treatments that can have a lasting impact on their daily life. Mon, 19 Oct 2026 12:19:38 EDT FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development The U.S. Food and Drug Administration, a division within the U.S. Department of Health and Human Services (HHS), today announced the Rare Disease Framework Initiative to reimagine the development of drugs and biologics for rare diseases. Wed, 14 Oct 2026 11:50:52 EDT